Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Orally active growth hormone secretagogue SM-130686 identified by Sumitomo

Dec. 27, 2001

Amgen initiates phase III AMG-073 trial for hyperparathyroidism

Dec. 27, 2001

Worldwide expansion of Merck/Schering-Plough cholesterol partnership

Dec. 27, 2001

Biora receives European Commission research grant for new matrix protein-based products

Dec. 24, 2001

Telik files IND application for TLK-199, a small molecule for myelodysplastic syndrome

Dec. 21, 2001

Encouraging oral insulin results obtained with BioSante's CAP delivery system

Dec. 20, 2001

Ferring reports new compounds inhibiting DPP-IV

Dec. 19, 2001

Obesity drug ATL-962 completes phase I development program

Dec. 19, 2001

Novo Nordisk patents new PPAR agonists useful for diabetes and obesity

Dec. 18, 2001

Trial initiated to treat cognitive function in type 2 diabetes with Avandia

Dec. 18, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 23, 2026.
Alicorn synthesizes new AAK1 inhibitors
BioWorld Science
Researchers from Alicorn Pharmaceutical Co. Ltd. and Jiangsu Alicorn Pharmaceutical Co. Ltd. have disclosed crystalline salts of compounds acting as...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
Have brain-computer interfaces finally arrived?
BioWorld
More and more individuals now have chronically implanted brain-computer interface (BCI) systems in their heads. Devices that can record and stimulate neural...
Nankai University and Accendatech present new majusculamide D derivatives
BioWorld Science
Scientists from Nankai University Tianjin and Accendatech Technology Co. Ltd. have identified a majusculamide D derivative found to be useful for the treatment of...